Clinical trials represent a critical juncture in the development of medical innovations. This was the central topic of the panel discussion "Clinical Trials – Potentials and Obstacles in Serbia," held on May 23, 2025, with significant input from the BIO4 Campus.

The discussion gathered experts from relevant institutions. Panelists included Aleksandra Vujačić Simić (ALIMS), Aleksandra Pešić (KLINIS Association), and Jadranka Mirković (BIO4 Campus), moderated by Dragana Šutović Ilić (NALED).

Challenges in Medical Device Testing

The panel focused on the clinical testing of medical devices, emphasizing the need to improve the training and competence of research teams, as well as the readiness of healthcare institutions. Discussions also covered the application of current regulations and the importance of harmonization with international standards, which is crucial for the development of the biomedical sector.

A particular emphasis was placed on the potential for collaboration between the scientific community and industry.

BIO4: The Link Between Science and Business

The development of medical devices requires synergy across three essential areas of expertise: technical, medical, and regulatory. The discussion highlighted the shared responsibility of all stakeholders to map, strengthen, and interconnect these segments.

This integration is the core of the BIO4 narrative. Efforts must be directed toward linking science, research, and entrepreneurship with existing industrial capacities. The BIO4 Campus is vital here, serving as a catalyst for bridging academic discovery and practical industry needs.

The Importance of Standardization for the Global Market

To ensure quality and competitiveness, the medical products industry must strictly adhere to internationally recognized standards such as ISO and GMP.

Adherence to these standards not only guarantees product quality but also opens doors for market expansion, particularly toward countries and healthcare systems with higher purchasing power. Companies that continuously apply and improve these practices demonstrate a commitment to excellence, which is crucial for growth and success in the global biomedical industry.